Key result
Jinlida granules significantly ameliorated high-fat-diet-induced obesity, maintained glucose and lipid homeostasis, and activated brown adipose tissue thermogenesis in mice.
Why the study?
Activation of brown adipose tissue thermogenesis contributes to energy expenditure critical for treating obesity and type 2 diabetes mellitus, but whether Jinlida granules could improve metabolic disorders via this mechanism remained unclear.
Does Jinlida (JLD) improve metabolic disorders and activate brown adipose tissue thermogenesis in high-fat diet-fed mice?
Does Jinlida (JLD) improve metabolic disorders and activate brown adipose tissue thermogenesis in high-fat diet-fed mice?
Jinlida granules improve high-fat diet-induced metabolic disorders in mice by activating brown adipose tissue thermogenesis, providing pharmacological evidence for its potential use in obesity and type 2 diabetes mellitus.
Answers are grounded in this paper and cite their sources.
May support BAT activation by Jinlida in obese mice; leaves open translation to human metabolic disease.
AIMS: Activation of brown adipose tissue (BAT) thermogenesis could contribute to energy expenditure, which is critical for the treatment of obesity and type 2 diabetes mellitus (T2DM). In the present study, we aimed to systematically investigate whether traditional Chinese medication Jinlida (JLD) granules could improve metabolic disorders and activate BAT thermogenesis in C57BL/6 J mice fed with a high-fat diet (HFD). METHODS: In the present study, JLD (3.8 g/kg) in 0.5% of carboxymethyl cellulose (CMC) solution was administrated daily by oral gavage to HFD-induced mice for 15 weeks. The body weight, biochemical analysis, histology analysis, intraperitoneal glucose and insulin tolerance (OGTT and ITT) tests were measured to explore metabolic disorders. Cold tolerance test, real-time PCR (qRT-PCR), immunohistochemistry, and western blot were performed to evaluate BAT function. RESULTS: As results, JLD treatment significantly ameliorated HFD-induced obesity and fat mass gain, maintained glucose and lipid homeostasis, and improved hepatic steatosis and inflammation. More importantly, we observed that JLD markedly activated BAT thermogenesis in HFD-induced obese mice. Moreover, our data confirmed that JLD promoted mitochondrial biogenesis and fatty acid oxidation metabolism in BAT. CONCLUSIONS: These data suggested that JLD could improve metabolic disorders in associated with activation of BAT thermogenesis via enhancement of mitochondrial biogenesis and fatty acid oxidation metabolism, thus providing a new pharmacological evidence for the clinical usage of JLD in T2DM treatment.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2019) studied High-fat-diet induced metabolic disorders. Jinlida (JLD) granules vs. Control (HFD alone) was evaluated on Metabolic disorders and BAT thermogenesis. Jinlida granules significantly ameliorated high-fat-diet-induced obesity, maintained glucose and lipid homeostasis, and activated brown adipose tissue thermogenesis in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: